Evaro

Name: Evaro
Brand: Evaro
Rating: 4.5 (10130 reviews)

We power your leap into digital health and connect more customers to the care they need.

Est 2017|6 Ref Customers

LinkedIn 3K|Web traffic 28K|FTEs 82

Published Sep 19, 2026

01Common complaints

- If you require transparent, publicly accessible partner pricing and immediately accessible developer documentation - Partner pricing is not public, and developer documentation was not found on public pages in the reviewed material. - If your procurement policy requires independently validated, publicly available security certifications - No SOC 2 / ISO certificates were identified on public pages; buyers should request evidence during procurement. - If your use case demands full primary care continuity (synchronous video visits, comprehensive longitudinal care) - The platform is oriented toward asynchronous prescribing and fulfillment for common conditions rather than comprehensive GP-level continuity. - If your organization cannot accept any operational risk related to fulfillment or packaging - Community and Trustpilot summaries indicate that packaging and delivery issues have been reported for some temperature-sensitive medications. - If regulatory risk tolerance is low and you need fully remediated regulator inspection histories prior to onboarding - A GPhC inspection outcome from Feb 2024 indicated standards were not all met for the distance-selling pharmacy; buyers should review subsequent inspection outcomes and evidence of remediation. - Current limitations acknowledged by the vendor - The Self-Service Portal is listed as "coming soon," indicating that fully self-serve onboarding for smaller partners is not yet generally available. - Regulatory/compliance limitations or gaps surfaced externally - The GPhC inspection (Feb 2024) and subsequent action plan identified gaps in prescribing risk management and monitoring for higher-risk medicines; remediation steps were described in the action plan. - Roadmap signals - Press coverage mentions plans for "API-first" infrastructure expansion and investments in diagnostics and aftercare; these items are forward-looking and should be validated as shipped features during diligence. - Scale limitations - Not explicitly documented; however, as with many vertically integrated care platforms, scaling clinician capacity, pharmacy throughput, and delivery SLA management is an operational risk as partner volumes increase. - API limitations or integration constraints - Public API reference documentation was not located in the reviewed material; many partner integrations appear to be embed-based or require bespoke integration work under commercial agreements.

Deal disqualifiers: what makes a POOR fit

Non-UK markets where the vendor’s UK regulatory licensing does not apply.
Use cases requiring high-touch longitudinal care, complex diagnostics, or extensive in-person examinations.
Organizations that require publicly documented SOC 2 / ISO certifications as a procurement gating item and cannot wait for vendor-supplied documentation.

Why some customers left for competitors (churn reasons)

Not directly measurable from accessible sources; community and Trustpilot summaries suggest drivers could include:
- Packaging and cold-chain confidence for temperature-sensitive medications.
- Responsiveness during order issues.
- Preference for more longitudinal clinical follow-up rather than a transaction-focused flow.

02Why they buy

- Competitive advantages supported by evidence (vendor claims corroborated in third-party content when available) - The vendor’s consumer-facing brand reviews indicate many customers report timely dispatch and a straightforward online ordering flow for certain treatments. - Vendor-provided partner case references and media coverage point to a partner-centric embedding model that combines consultation, prescribing, and fulfillment. - Unique features and capabilities relative to competitors (as positioned) - A partner-focused embedding approach intended for non-healthcare brands to offer prescription services in-app or on-site without building a full clinical and pharmacy stack. - Vendor-managed clinical and pharmacy operations coupled with partner integration options. - Differentiation from competitors based on reviews - High volume of positive consumer reviews for the consumer-facing brand suggests broad consumer satisfaction for that channel; however, consumer ratings do not substitute for partner-level procurement evidence. - Areas where competitors have advantages - ZAVA: more transparent consumer pricing and a long-established consumer telemedicine presence. - Kry/Livi: synchronous consult and continuity capabilities better suited to some primary-care needs. - Numan/Manual: stronger vertical DTC brand and subscription engagement in specific categories.

Why customers chose this product over alternatives (from available evidence)

For patients using the consumer-facing brand: price and convenience via asynchronous questionnaires and home delivery.
For partners: vendor statements and third-party accounts indicate reasons such as speed to launch and access to an integrated clinical and pharmacy stack without building those capabilities in-house.

03Field reports

Important scope note on reviews

Evaro is primarily a B2B platform; much of the accessible consumer review content relates to its patient-facing brand e-Surgery and associated Trustpilot pages, along with community posts discussing e-Surgery/Evaro.
B2B SaaS review platforms (G2, TrustRadius, Gartner Peer Insights) did not surface a clearly indexed, verified product profile for Evaro with a sizable, verified review set in the searches conducted.

Trustpilot (e-Surgery & EVARO)

- Trustpilot shows a large review volume and a high average rating in the material captured, while also flagging recurring negative themes such as delivery/packaging issues and occasional support responsiveness concerns. - Examples - Some reviews describe severe negative experiences alongside many positive reviews; Trustpilot’s AI-generated summary highlights recurring negative topics. - Many positive reviews reference timely dispatch and convenience, while negative reviews reference damaged or warm deliveries and slow or unresponsive customer service in some cases.

Reddit / community discussions (e-Surgery / Evaro)

- Positive/neutral examples - Some users reported fast dispatch, tracked delivery, and satisfactory inclusion of items such as swabs or needles. - Negative examples / complaints - Community threads include reports of temperature-sensitive medication arriving warm. - Confusion around expiry and manufacturer-issued expiry extensions was reported in community threads, indicating potential communication or packaging insert issues. - Several threads report difficulty contacting support or dissatisfaction with responsiveness; these are anecdotal and vary in detail.

Vendor/partner testimonials (marketing)

Partner quotes on the vendor site are uniformly positive and should be treated as vendor-provided testimonials rather than independent verification (examples include quotes from partner CTOs and CEOs).

Specific outcomes customers achieved (with metrics when available)

Vendor-published claims include serving millions of patients, tens of thousands of prescriptions monthly, and multi-million-pound revenue generated for partner brands. These are vendor-provided figures and do not include attributable methodologies on the public pages captured.

AgileBusiness.org case study (operations/agility)

A published PDF case study describes Evaro’s internal operating model (agile practices and delivery cadence).
Value
- Useful for assessing organizational maturity and delivery processes (the case study references regular releases and OKRs).
Limitations
- The document focuses on internal processes rather than customer ROI and is not independently verified.

Partner examples on vendor site

The vendor lists partner logos and includes partner quotes (e.g., Patchs, Clue, Lovehoney).
Limitations
- These are curated and promotional; they do not provide independent performance metrics or counterfactuals.

Lovehoney embedded NHS service coverage (third-party)

Media coverage notes Lovehoney embedded an NHS-related contraception service via the vendor platform; the exact commissioning, eligibility, and funding details require further validation.

04Best fit

Company sizes

Likely best fit:
- Consumer brands and apps with substantial UK user bases (e.g., a large monthly active user base) that can generate consultation volume.
- Mid-market to enterprise brands able to support compliance reviews and partnership management.
The Self-Service Portal (announced as coming soon) indicates the vendor may also pursue smaller partners with lighter onboarding.

Industries and verticals where adoption is strongest (with customer examples)

Sexual wellness retail (partnership referenced in press coverage with Lovehoney).
Women’s health and cycle tracking (partnership referenced with Clue).
Digital health brands and the vendor’s own consumer-facing brand (e-Surgery) are referenced publicly.

Roles and personas

Decision makers
- Head of Product / VP Product
- Head of New Revenue / Partnerships
- Chief Medical Officer / Clinical Governance lead
- Legal/Compliance and Data Protection Officer
End users
- Patients/customers using the embedded service
- Partner customer support teams coordinating with the vendor’s patient support

Pain points and challenges the product addresses

Brands that want to offer prescription services without building clinical operations, managing pharmacy inventory, or directly managing regulatory relationships.

Qualification criteria: what makes a GOOD fit

Established brand trust in the target market.
Ability to integrate and market the service in compliance with healthcare advertising and governance requirements.
High-intent use cases such as sexual health, contraception, weight management, and common condition treatments.

Real customer examples

Patchs (vendor testimonial on site).
Clue (vendor testimonial on site).
Lovehoney (media coverage of an integrated service).

05The pitch

What the product does (core value proposition in objective terms)

- Evaro is a UK-based embedded healthcare / healthcare-as-a-service platform that enables third-party brands and healthcare organizations to offer regulated, prescription-based digital health journeys within their own customer experience. - The vendor describes the product as infrastructure analogous to payment platforms such as Stripe: one integration intended to cover asynchronous questionnaires, clinician review and prescribing, dispensing via a regulated pharmacy operated by Evaro, delivery, and aftercare. - The vendor states that integration timelines can be very short (days to a few weeks for some integrations) and that partners do not need to maintain their own clinical teams or separate pharmacy supplier relationships when using the platform.

Target market and market positioning

- Primary: consumer-facing brands (retailers, apps, communities) that want to add prescription services as a monetizable feature and a retention mechanism (B2B2C model). - Secondary: healthcare organizations and employers that want to expand digital capacity or benefits, per vendor fundraising press coverage. - Positioning: regulated integrated clinical, pharmacy, and fulfillment services with partner-facing integration options (white-label or platform integration).

Get a comprehensive analysis of Evaro including market position, competitive landscape, adoption trends, and peer benchmarks.

Download full report →